{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:55:25Z","timestamp":1793228125036,"version":"4.5.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United Way Worldwide grant","award":["17245"],"award-info":[{"award-number":["17245"]}]},{"DOI":"10.13039\/100005945","name":"Izumi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI083088, P30AI051519"],"award-info":[{"award-number":["K23AI083088, P30AI051519"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Research Corporation (URC) South Africa"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196003","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T14:29:26Z","timestamp":1524061766000},"page":"e0196003","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9205-9314","authenticated-orcid":true,"given":"Marian","family":"Loveday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Wallengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarylee","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donela","family":"Besada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C. M.","family":"Brust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Voce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Ngozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanele","family":"Radebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Master","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesri","family":"Padayatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Daviaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation. Global Tuberculosis Report 2017. WHO\/HTM\/TB\/2017.23. 2017; Geneva, Switzerland."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/11595340-000000000-00000","article-title":"A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis","volume":"30","author":"C Fitzpatrick","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"ref3","article-title":"GeneXpert MTB\/RIF Progress Report, July 2014","year":"2014"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.13-0004","article-title":"A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis","volume":"89","author":"A Bassili","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1183\/09031936.00169411","article-title":"Cost and cost-effectiveness of multidrugresistant tuberculosis treatment in Estonia and Russia","volume":"40","author":"K Floyd","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/tmi.12018","article-title":"Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa","volume":"8","author":"K Schnippel","year":"2013","journal-title":"Trop Med Int Health"},{"key":"ref7","article-title":"Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based program in Khayelitsha, South Africa","author":"H Cox","year":"2015","journal-title":"Trop Med Int Health"},{"key":"ref8","unstructured":"National Institute for Communicable Diseases. South African Tuberculosis Drug Resistance Survey 2012\u20132014. Johannesburg: National Institute for Communicable Diseases, 2016."},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e94016","DOI":"10.1371\/journal.pone.0094016","article-title":"Association between Health Systems Performance and Treatment Outcomes in Patients Co-Infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: Implications for TB Programmes","volume":"9","author":"M Loveday","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5588\/ijtld.14.0369","article-title":"Community-based care vs. centralised hospitilisation for MDR-TB patients KwaZulu-Natal, South Africa","volume":"19","author":"M Loveday","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","unstructured":"South African Department of Health. Multi-drug resistant tuberculosis: A policy framework on decentralised and deinstitutionalised managment for South Africa. 2011;Pretoria, South Africa."},{"issue":"10","key":"ref12","first-page":"1913","article-title":"Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001\u20132007","volume":"17","author":"K Wallengren","year":"2011","journal-title":"EID"},{"key":"ref13","article-title":"District Health Barometer 2010\/11","author":"C Day","year":"2012"},{"issue":"6","key":"ref14","first-page":"640","article-title":"Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis","volume":"9","author":"K Laserson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","unstructured":"World Health Organisation. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency Update 2008. WHO\/HTM\/TB\/2008.402. Geneva: World Health Organisation, 2008."},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15598608.2012.695571","article-title":"Median-Based Incremental Cost-Effectiveness Ratio (ICER)","volume":"6","author":"H Bang","year":"2012","journal-title":"Journal of statistical theory and practice"},{"key":"ref17","article-title":"National Department of Public Service and Administration","year":"2012"},{"key":"ref18","article-title":"KwaZulu-Natal Financial Reports","year":"2012"},{"key":"ref19","unstructured":"StatsSA. Consumer Price Index: Release P0141. Stats South Africa, Pretoria, January 2013 and January 2014."},{"key":"ref20","unstructured":"United Nations. UN Operational Rates of Exchange Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/treasury.un.org\" xlink:type=\"simple\">https:\/\/treasury.un.org<\/ext-link>. Accessed March 2015. 2015."},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"P Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"ref22","unstructured":"World Health Organisation. WHO treatment guidelines for drug-resistant tuberculosis 2016 update, October 2016 revision. WHO\/HTM\/TB\/2016.04. Geneva, Switzerland2016."},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5588\/ijtld.13.0742","article-title":"Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa","volume":"18","author":"H Cox","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5588\/ijtld.12.0537","article-title":"Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis","volume":"17","author":"A Toczek","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"e54587","DOI":"10.1371\/journal.pone.0054587","article-title":"What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?","volume":"8","author":"A Pooran","year":"2013","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5588\/ijtld.14.0421","article-title":"Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa","volume":"19","author":"E Sinanovic","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4269\/ajtmh.13-0004","article-title":"Review Article: A Systematic Review of the Effectiveness of Hospital- and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis","volume":"89","author":"A Bassili","year":"2013","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5588\/ijtld.11.0153","article-title":"Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting","volume":"16","author":"N Gandhi","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"ref30","first-page":"1","article-title":"How providers influence the implementation of provider-initiated HIV testing and counseling in Botswana: a qualitative study","volume":"11","author":"S Ahmed","year":"2016","journal-title":"Implementation Science"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.5588\/ijtld.15.0262","article-title":"Global-to-local policy transfer in the introduction of new molecular tuberculosis diagnostics in South Africa","volume":"19","author":"C Colvin","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref32","first-page":"42","article-title":"The economic burden of TB diagnosis and treatment in South Africa. Social Science &amp;","volume":"130","author":"N Foster","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5588\/ijtld.17.0371","article-title":"Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa","volume":"22","author":"M Loveday","year":"2018","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"ref34","article-title":"Census 2011: Statistical Release P0301.4.","year":"2013"},{"key":"ref35","article-title":"The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015","year":"2015"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"e1001675","DOI":"10.1371\/journal.pmed.1001675","article-title":"Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru","volume":"11","author":"T Wingfield","year":"2014","journal-title":"PLoS medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:04:59Z","timestamp":1540343099000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196003"}},"subtitle":[],"editor":[{"given":"Joan A.","family":"Cayl\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196003","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]}}}